Frovatriptan Succinate
CAS 158930-17-7Small Molecule
Overview
Frovatriptan Succinate is a selective 5-HT receptor agonist used to treat migraine attacks. It has a higher affinity for the 5-HT1B and 5-HT1D receptors, contributing to its efficacy in alleviating headache symptoms.
Therapeutic areas
NeurologyPain Management
Verified Supplier Partner
Do you supply Frovatriptan Succinate? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.